Page 188 - Genentech News Today

The method will be allowed only if lethal injection drugs aren't available. As AP explains, pharmaceutical companies increasingly have barred executioners from using their drugs, saying they were meant to save lives. Also in the news: Fines for L.A. Care; California's plan for cheap insulin; Medicaid for housing; and more.

Healio Rheumatology | For more than a decade, the medical community as a whole, and particularly the field of rheumatology, has been trying to move away from opioids for the management of chronic pain — with varying degrees of success.However, for a growing number of medical experts — in rheumatology and elsewhere — a completely new paradigm and understanding of pain, and its management, is needed.

Genentech, Roches biotech company based in South San Francisco, is closing a plant and laying off 265 workers.

Biotech giant Genentech plans to lay off more than 265 employees in its South San Francisco production facility and end manufacturing.

Genentech lays off 265 employees in South San Francisco

Johannesburg (South Africa), Woippy (France) — March 27th 2023 Roche Diagnostics (Pty)...

Budget committee clears $210 million, plus supersiting authority for governor, to up-or-down votes by the Senate and House in the coming week.

There is no way you will talk about the Biotech Industry without referring Genentech. They represent the bridge between the past and future of the.........

Bay Area biotech giant Genentech is laying off 265 workers as part of its plan to close a manufacturing plant in South San Francisco, the company confirmed…

Since 2014, 10 immunotherapies have been approved by the FDA, including 6 CAR T-cell therapies and 4 BiTE therapies.